• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Study refutes 'conventional' dose griseofulvin in tinea capitis Tx

Lubbock, Texas - Results of a retrospective study evaluating recurrence rates following successful griseofulvin treatment for tinea capitis confirm what most dermatologists knew from their clinical experience - that the dose of griseofulvin used to treat this fungal infection should be at least 20 mg/kg/day.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.